Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Downs

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Ophthalmology|October 6, 2009
Outcome measures to assess efficacy of treatments for age-related macular degenerationJanet Wittes, Matthew Downs
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 26, 2021
Reply to Ramirez and Diaz-QuijanoMatthew B Laurens, Matthew Downs, Miriam K Laufer
Developmental Neurorehabilitation|June 5, 2020
Current Experiences and Future Expectations for Physical Activity Participation: Perspectives of Young People with Physical Disabilities and Their Rehabilitation CliniciansMatthew Downs, Joy MacDermid, Denise Connelly, et al.
Therapeutic Innovation & Regulatory Science|May 2, 2018
Reports to Independent Data Monitoring Committees: An Appeal for Clarity, Completeness, and ComprehensibilityKevin A Buhr, Matthew Downs, Janelle Rhorer, et al.
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control|May 27, 2014
Transcranial cavitation detection in primates during blood-brain barrier opening--a performance assessment studyShih-Ying Wu, Yao-Sheng Tung, Fabrice Marquet, et al.
Plos One|February 8, 2014
Real-time, transcranial monitoring of safe blood-brain barrier opening in non-human primatesFabrice Marquet, Tobias Teichert, Shih-Ying Wu, et al.
The Lancet. Child & Adolescent Health|August 19, 2018
Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort studyMiriam Nickel, Alessandro Simonati, David Jacoby, et al.
Vaccines|June 27, 2024
Effect of Prior ChAdOx1 COVID-19 Immunisation on T-Cell Responses to ChAdOx1-HBVCharlotte Davis, Dave Singh, Katie Anderson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 2021
Revisiting Co-trimoxazole Prophylaxis for African Adults in the Era of Antiretroviral Therapy: A Randomized Controlled Clinical TrialMatthew B Laurens, Randy G Mungwira, Nginache Nampota, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2025
A Phase 1b/2, Randomised, Placebo-controlled Study to Evaluate Safety, Tolerability, Efficacy, and Immunogenicity of VTP-200, a Chimpanzee Adenovirus and Modified Vaccinia Ankara-vectored Multigenotype High-Risk Human Papillomavirus Vaccine in Women with Low-grade Cervical LesionsKarin Hellner, Philippe Simon, Philippe De Sutter, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Ophthalmology|October 6, 2009
Outcome measures to assess efficacy of treatments for age-related macular degenerationJanet Wittes, Matthew Downs
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 26, 2021
Reply to Ramirez and Diaz-QuijanoMatthew B Laurens, Matthew Downs, Miriam K Laufer
Developmental Neurorehabilitation|June 5, 2020
Current Experiences and Future Expectations for Physical Activity Participation: Perspectives of Young People with Physical Disabilities and Their Rehabilitation CliniciansMatthew Downs, Joy MacDermid, Denise Connelly, et al.
Therapeutic Innovation & Regulatory Science|May 2, 2018
Reports to Independent Data Monitoring Committees: An Appeal for Clarity, Completeness, and ComprehensibilityKevin A Buhr, Matthew Downs, Janelle Rhorer, et al.
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control|May 27, 2014
Transcranial cavitation detection in primates during blood-brain barrier opening--a performance assessment studyShih-Ying Wu, Yao-Sheng Tung, Fabrice Marquet, et al.
Plos One|February 8, 2014
Real-time, transcranial monitoring of safe blood-brain barrier opening in non-human primatesFabrice Marquet, Tobias Teichert, Shih-Ying Wu, et al.
The Lancet. Child & Adolescent Health|August 19, 2018
Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort studyMiriam Nickel, Alessandro Simonati, David Jacoby, et al.
Vaccines|June 27, 2024
Effect of Prior ChAdOx1 COVID-19 Immunisation on T-Cell Responses to ChAdOx1-HBVCharlotte Davis, Dave Singh, Katie Anderson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 2021
Revisiting Co-trimoxazole Prophylaxis for African Adults in the Era of Antiretroviral Therapy: A Randomized Controlled Clinical TrialMatthew B Laurens, Randy G Mungwira, Nginache Nampota, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2025
A Phase 1b/2, Randomised, Placebo-controlled Study to Evaluate Safety, Tolerability, Efficacy, and Immunogenicity of VTP-200, a Chimpanzee Adenovirus and Modified Vaccinia Ankara-vectored Multigenotype High-Risk Human Papillomavirus Vaccine in Women with Low-grade Cervical LesionsKarin Hellner, Philippe Simon, Philippe De Sutter, et al.
Pageof 2